e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Respiratory function assessment in disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The predictive values of bronchodilator reversibility indicators in asthmatic patients with non-obstructive patterns of spirometry
T. Merghani (RAK, United Arab Emirates)
Source:
International Congress 2019 – Respiratory function assessment in disease
Session:
Respiratory function assessment in disease
Session type:
Thematic Poster
Number:
1126
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Merghani (RAK, United Arab Emirates). The predictive values of bronchodilator reversibility indicators in asthmatic patients with non-obstructive patterns of spirometry. 1126
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012
Pre- and post-bronchodilator spirometric values and the degree of reversibility in patients with COPD
Source: Eur Respir J 2004; 24: 332
Year: 2004
Should bronchodilator response be assessed in all asthmatic children with normal baseline spirometry?
Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children
Year: 2018
Assessment of diagnostic accuracy of lung function indices and FeNO for a positive methacholine challenge in suspected asthmatics
Source: International Congress 2018 – Asthma management
Year: 2018
Immediate bronchodilation response in FEV1 as a diagnostic criterion of adult asthma
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018
Immediate bronchodilator response in FEV
1
as a diagnostic criterion for adult asthma
Source: Eur Respir J, 53 (2) 1800904; 10.1183/13993003.00904-2018
Year: 2019
Spirometric changes in bronchodilation tests as predictors of asthma diagnosis and treatment response in patients with FEV1 =80% predicted
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021
Should reversibility be assessed in all asthmatic children with normal spirometry?
Source: Eur Respir J, 52 (2) 1800373; 10.1183/13993003.00373-2018
Year: 2018
A comparison between the diagnostic value of bronchodilator response in spirometry and questionnaire in determining asthma
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Measuring the bronchial reversibility in asthmatic children - clinical value of different indices
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
Should normal baseline spirometry negate the need to investigate bronchodilator responsiveness in asthmatic patients?
Source: Eur Respir J 2005; 26: Suppl. 49, 582s
Year: 2005
Diagnostic value of spirometric parameters in bronchial remodeling estimation in asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 220s
Year: 2006
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI
Source: Virtual Congress 2020 – New imaging techniques applied to old problems
Year: 2020
Predictive value of spirometry trend and FeNO for difficult to treat asthma in children
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010
Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020
Usefulness of post bronchodilator FVC in the evaluation and spirometric evolution of COPD patients
Source: Annual Congress 2013 –Monitoring lung function in airway diseases
Year: 2013
COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers
Source: Eur Respir J 2014; 43: 54-63
Year: 2004
The predictive value of baseline spirometry values and reversibility history of the patient for a significant reversibility response in children
Source: Eur Respir J 2002; 20: Suppl. 38, 539s
Year: 2002
Accuracy of spirometry in predicting restrictive pulmonary impairment using different spirometric reference values in Chilean population
Source: Eur Respir J 2006; 28: Suppl. 50, 203s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept